ATE186541T1 - Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung - Google Patents

Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung

Info

Publication number
ATE186541T1
ATE186541T1 AT96909390T AT96909390T ATE186541T1 AT E186541 T1 ATE186541 T1 AT E186541T1 AT 96909390 T AT96909390 T AT 96909390T AT 96909390 T AT96909390 T AT 96909390T AT E186541 T1 ATE186541 T1 AT E186541T1
Authority
AT
Austria
Prior art keywords
quillajasaponin
supplement
formulation containing
vaccine formulation
containing same
Prior art date
Application number
AT96909390T
Other languages
English (en)
Inventor
Hong-Seob So
Hye-Sung Yoon
Young-Sun Kwon
Joong-Myung Cho
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Application granted granted Critical
Publication of ATE186541T1 publication Critical patent/ATE186541T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96909390T 1995-04-13 1996-04-12 Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung ATE186541T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19950008589 1995-04-13
KR19950008590 1995-04-13

Publications (1)

Publication Number Publication Date
ATE186541T1 true ATE186541T1 (de) 1999-11-15

Family

ID=37027969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909390T ATE186541T1 (de) 1995-04-13 1996-04-12 Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung

Country Status (16)

Country Link
US (1) US5817314A (de)
EP (1) EP0765333B1 (de)
JP (1) JP2761809B2 (de)
KR (1) KR0184779B1 (de)
CN (2) CN1044478C (de)
AR (1) AR001618A1 (de)
AT (1) ATE186541T1 (de)
AU (1) AU678941B2 (de)
BR (1) BR9606311A (de)
CA (1) CA2190344C (de)
DE (1) DE69605094T2 (de)
DK (1) DK0765333T3 (de)
ES (1) ES2140837T3 (de)
MX (1) MX9601378A (de)
TW (1) TW442293B (de)
WO (1) WO1996032401A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
AU734180B2 (en) * 1997-08-29 2001-06-07 Antigenics Llc Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
US6262029B1 (en) 1998-08-14 2001-07-17 Galenica Pharmaceuticals, Inc. Chemically modified saponins and the use thereof as adjuvants
TW586935B (en) * 1998-09-14 2004-05-11 Kitasato Inst Saponin-containing vaccine preparation
ES2284287T3 (es) * 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
US6905712B2 (en) * 1999-12-08 2005-06-14 Statens Veterinarmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminum salt
WO2001041802A1 (en) * 1999-12-08 2001-06-14 Statens Veterinärmedicinska Anstalt Vaccine adjuvants comprising ginseng plant extract and added aluminium salt
US8883170B2 (en) * 2008-09-03 2014-11-11 Western Illinois University Research Foundation Adjuvant
EP2359698B1 (de) 2010-01-22 2013-12-04 Symrise AG Zusammensetzungen mit einem Tensidsystem mit Saponinen und Lecithin
EP2359702B1 (de) 2010-01-22 2014-06-04 Symrise AG Solubilisierungsmittel zum Löslichmachen von Polyphenolen, Flavonoiden und/oder Diterpenoidglucosiden
CN103347529B (zh) 2010-12-09 2016-10-26 Y&B妈妈之选有限公司 包含皂苷的制剂及其用途
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
US10064881B2 (en) 2010-12-09 2018-09-04 Y&B Mother's Choice Ltd. Natural formulations
EP2628398B1 (de) 2012-02-19 2016-09-07 Symrise AG Stoffgemische
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
CN105213471A (zh) * 2014-05-29 2016-01-06 江口县苗药生物科技有限公司 一种皂树皮总皂苷的提取工艺
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
CA3083059A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin extraction
TWI820099B (zh) * 2018-03-28 2023-11-01 台灣浩鼎生技股份有限公司 新穎皂素佐劑及其評估方法
WO2020245207A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification
CN116355035B (zh) * 2021-12-28 2024-03-12 成都迈科康生物科技有限公司 一种qs21免疫佐剂的制备方法
CN116139265A (zh) * 2023-04-06 2023-05-23 浙江洪晟生物科技股份有限公司 一种含黄芪多糖的兽用纳米乳佐剂及其制备方法和应用
CN119971022A (zh) * 2025-04-15 2025-05-13 北京华诺泰生物医药科技有限公司 一种qs-21复合佐剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057540A (en) * 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
PT692974E (pt) * 1993-03-29 2003-09-30 Pfizer Vacinas clostridiais com multiplos componentes usando adjuvantes de saponina

Also Published As

Publication number Publication date
EP0765333B1 (de) 1999-11-10
CN1149875A (zh) 1997-05-14
CA2190344C (en) 2001-04-10
MX9601378A (es) 1997-04-30
DE69605094D1 (de) 1999-12-16
TW442293B (en) 2001-06-23
AR001618A1 (es) 1997-11-26
CN1044478C (zh) 1999-08-04
JP2761809B2 (ja) 1998-06-04
JPH09510740A (ja) 1997-10-28
US5817314A (en) 1998-10-06
CN1262958A (zh) 2000-08-16
KR0184779B1 (ko) 1999-04-01
CA2190344A1 (en) 1996-10-16
EP0765333A1 (de) 1997-04-02
ES2140837T3 (es) 2000-03-01
DE69605094T2 (de) 2000-07-06
AU5290096A (en) 1996-10-30
AU678941B2 (en) 1997-06-12
BR9606311A (pt) 1997-09-16
KR960037694A (ko) 1996-11-19
WO1996032401A1 (en) 1996-10-17
DK0765333T3 (da) 2000-03-13

Similar Documents

Publication Publication Date Title
IL114759A (en) Benzoxazole derivatives and pharmaceutical compositions containing them
DE69509574D1 (de) Silikonvesikeln und Einschlussprodukte
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
FI955042A7 (fi) Syklosporiinia sisältävä jauhemainen koostumus
BR9500784A (pt) Composto e formulação farmacêutica
DK0858325T3 (da) Stabil frysetørret farmaceutisk formulering
BR9504060A (pt) Composto e formulação farmacêutica
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
EP0950665A4 (de) Veränderte physiologisch aktive proteine und medizinische verbindungen, die diese beinhalten
DE69605094D1 (de) Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung
BR9601032A (pt) Micropartícula e formulação de vacina de dose única
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL115563A0 (en) Benzoxazole derivatives and pharmaceutical compositions containing the same
DE69608973D1 (de) Schalter und diesen enthaltende Schaltungsanordnung
IL112521A0 (en) Pharmaceutical formulation
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
NO981008D0 (no) Farmasöytisk formulering
DE69400318D1 (de) Silikon enthaltende Hautpflegezusammensetzungen
DE69312499D1 (de) Kautschukzusammensetzungen enthaltend epoxidierten naturkautschuk und naturkautschuk
FI941447A7 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
BR9509688A (pt) Composto e composição farmacêutica
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties